TOP2B


Summary: This gene encodes a DNA topoisomerase, an enzyme that controls and alters the topologic states of DNA during transcription. This nuclear enzyme is involved in processes such as chromosome condensation, chromatid separation, and the relief of torsional stress that occurs during DNA transcription and replication. It catalyzes the transient breaking and rejoining of two strands of duplex DNA which allows the strands to pass through one another, thus altering the topology of DNA. Two forms of this enzyme exist as likely products of a gene duplication event. The gene encoding this form, beta, is localized to chromosome 3 and the alpha form is localized to chromosome 17. The gene encoding this enzyme functions as the target for several anticancer agents and a variety of mutations in this gene have been associated with the development of drug resistance. Reduced activity of this enzyme may also play a role in ataxia-telangiectasia. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2016].

NameOMIM IDEnsembl IDHGNC IDPHARMGKB IDMap Location
DNA topoisomerase II betaMIM:126431Ensembl:ENSG00000077097HGNC:HGNC:11990PA366723p24.2

GO terms in TOP2B


Term TypeEvidence TypeGO Term IDGO Des.
MFIEAGO:0003677DNA binding
MFIDAGO:0003682chromatin binding
MFIDAGO:0003918DNA topoisomerase type II (ATP-hydrolyzing) activity
MFIPIGO:0005080protein kinase C binding
MFIEAGO:0005524ATP binding
MFIPIGO:0008022protein C-terminus binding
MFIPIGO:0019899enzyme binding
MFIPIGO:0042826histone deacetylase binding
MFIEAGO:0046872metal ion binding
MFIPIGO:0046982protein heterodimerization activity
BPIBAGO:0000712resolution of meiotic recombination intermediates
BPIBAGO:0000819sister chromatid segregation
BPIEAGO:0001764neuron migration
BPIDAGO:0006265DNA topological change
BPIEAGO:0007409axonogenesis
BPIEAGO:0030900forebrain development
BPIBAGO:0044774mitotic DNA integrity checkpoint
CCIDAGO:0000792heterochromatin
CCIBAGO:0005634nucleus
CCIDAGO:0005634nucleus
CCIDAGO:0005654nucleoplasm
CCTASGO:0005654nucleoplasm
CCIDAGO:0005730nucleolus
CCIDAGO:0005829cytosol
CCISSGO:1990904ribonucleoprotein complex

Gene expression in normal tissue: TOP2B

Gene-model tissue-cancer distribution: Bubble Plot

Gene-drug pathway distribution

Pathways in TOP2B


DatabasePathway IDPathway Des.
smpdbSMP00442Etoposide Action Pathway
smpdbSMP00601Etoposide Metabolism Pathway
pharmgkbPA165292164Doxorubicin Pathway (Cardiomyocyte Cell), Pharmacodynamics
pharmgkbPA2025Etoposide Pathway, Pharmacokinetics/Pharmacodynamics
reactomeR-HSA-2990846SUMOylation
reactomeR-HSA-3108232SUMO E3 ligases SUMOylate target proteins
reactomeR-HSA-392499Metabolism of proteins
reactomeR-HSA-4615885SUMOylation of DNA replication proteins
reactomeR-HSA-597592Post-translational protein modification

Gene-Drug: Aster Plot


Drug IDDrug NameModel Num.
iGMDRD330BRD41324
iGMDRD599Salermide2
iGMDRD772BRD47703
iGMDRD144NSC953974
iGMDRD424Tamatinib2
iGMDRD523Cyanoquinoline, 112
iGMDRD446LY 21832402
iGMDRD85Ursolic acid1
iGMDRD351GW843682X2
iGMDRD394BX-7951
iGMDRD466Chaetocin3
iGMDRD280CYTOCHALASIN B3
iGMDRD132(-)-gallocatechin-3-O-gallate2
iGMDRD289Parthenolide3
iGMDRD221Tamoxifen2
iGMDRD192CIL563
iGMDRD782DC-45-A23
iGMDRD434BMS-5369243
iGMDRD441TW 372
iGMDRD77Itraconazole2
iGMDRD52Rotenone4
iGMDRD188Piperlongumine3
iGMDRD286Nsc 6328394
iGMDRD871BRD63682
iGMDRD887Compound 23 citrate2
iGMDRD662JQ-12
iGMDRD577BIX012942
iGMDRD147Prima-11
iGMDRD369TGX-1152
iGMDRD268Cerulenin2

Gene in drug-gene network: Network Plot

Gene-drug targets distribution

Gene Structure: PDB

Models in TOP2B

​​​​